Editas Medicine (EDIT) Stock Highlights

3.88 | +0.52%

2024-09-19 04:51:54

Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The companys only operating segment is developing and commercializing genome editing technology.

Statistics

Range Today

3.86 4.12

Volume Today 3.1M

Range 1 Year

3.4 11.69

Volume 1 Year 473.57M

Range 3 Year

3.4 62.4

Volume 3 Year 1.35B

Range 10 Year

3.4 99.95

Volume 10 Year 2.79B

Highlights

Market Capitalization 325.78M (small)

Floating Shares 76.13M

Current Price 3.88

Price To Earnings -1.63

Price To Revenue 1.03

Price To Book 1.4

Earnings Per Share -2.33

Payout Ratio 0%

Performance

Latest +0.52%

1 Month -3.24%

3 Months -26.65%

6 Months -52.1%

1 Year -53.75%

3 Years -93.56%

5 Years -85.08%

10 Years -78.44%

Benchmarks

Market Capitalization

148 / 368

Gross Profits

255 / 278

Total Revenue

151 / 300

Total Rank

314 / 368

Free Cashflow

279 / 352

Performance 5 years

268 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.